Announcing Our New Executive Director – Scott Bernstein

September 1st, 2021 MAPS Canada is pleased to announce the appointment of Scott Bernstein as our new Executive Director. A lawyer based in Vancouver, BC, Scott brings over 13 years’ experience in national and international drug policy reform. Prior to joining MAPS Canada, Scott served as Director of Policy for the Canadian Drug Policy Coalition, …

Announcing Our New Executive Director – Scott Bernstein Read More »

MDMA Pharmacology

Introduction Over the past several years, MDMA (also known as Ecstasy/Molly) has been making waves in the realms of drug research and therapy, with many efforts having been largely spearheaded by MAPS. Recognized for its ability to enhance feelings of empathy and bonding among users, research has largely aimed at examining MDMA’s therapeutic potential for …

MDMA Pharmacology Read More »

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial

Objective The Center for Psychedelic and Consciousness Research at Johns Hopkins Medical school in Baltimore conducted a randomized, controlled clinical trial to examine if one or two administrations of psilocybin, in addition to psychological support, could be an effective treatment for patients suffering from major depressive disorder (MDD).  What is Major Depressive disorder? Major depressive …

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial Read More »

Announcing Vivian Smith As Our New Interim Executive Director

April 16, 2021 The MAPS Canada Board of Directors is pleased to announce the appointment of Vivian Smith on April 12, 2021, as the organization’s Interim Executive Director. Vivian will lead MAPS Canada over the next three months while the board continues the recruitment process for a full-time, permanent Executive Director. Vivian will continue to …

Announcing Vivian Smith As Our New Interim Executive Director Read More »

Inclusion of People of Color in Psychedelic-Assisted Psychotherapy: A Review of The Literature

Are people of colour included in psychedelic research? In their paper “Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature” Michaels et al. (2018) reviewed studies on psychedelic-assisted psychotherapy published between 1993 and 2017 across countries to examine rates of inclusion for people of colour. Below we have summarized the key …

Inclusion of People of Color in Psychedelic-Assisted Psychotherapy: A Review of The Literature Read More »

Why Learn How to Read Scientific Papers?

In Kyle Shannon’s Towards Data Science’s article, “A Guide to Reading Academic Research”, Shannon emphasizes that reading scientific papers is not just for gathering the right information for a good grade or bragging rights. “Reading papers certainly builds character”, he suggests.  From researcher, to child, to performance athlete, we all have experience in building character …

Why Learn How to Read Scientific Papers? Read More »

Stay connected with MAPS Canada

Join our mailing list and stay informed of the latest news from MAPS Canada, relevant news about psychedelics from around the world, and invitations to MAPS Canada virtual events, webinars, in-person events, and more.